Insider Trading March 24, 2026

BCP Investment Compliance Chief Adds $6,894 Stake as Shares Hover Near 52-Week Low

David Held reports purchase of 938 shares; company posts Q4 2025 beats even as NAV and net investment income show weakness

By Ajmal Hussain BCIC
BCP Investment Compliance Chief Adds $6,894 Stake as Shares Hover Near 52-Week Low
BCIC

David Held, Chief Compliance Officer at BCP Investment Corp (NASDAQ: BCIC), purchased 938 shares on March 23, 2026, totaling $6,894. The transaction leaves Held with 1,258 shares. The stock is trading close to its 52-week low, and the firm reported quarterly results that beat consensus on EPS and revenue while other metrics, including net asset value and net investment income, showed deterioration prompting a price-target cut from Keefe, Bruyette & Woods.

Key Points

  • BCP Investment Chief Compliance Officer David Held bought 938 shares at $7.35 on March 23, 2026, totaling $6,894.
  • After the purchase Held holds 1,258 shares; BCIC was trading at $7.45 and near its 52-week low of $7.15, down 10% over the prior week.
  • BCP Investment beat Q4 2025 EPS ($0.57 vs $0.5325) and revenue ($17.5M vs $16.98M) while KBW cut its price target to $9.00, citing weaker net investment income and a 5% NAV decline.

David Held, the Chief Compliance Officer of BCP Investment Corp (NASDAQ: BCIC), disclosed a purchase of 938 shares of the companys common stock on March 23, 2026, in a Form 4 filing with the Securities and Exchange Commission. The shares were acquired at $7.35 apiece, producing a total outlay of $6,894.

Following the reported buy, Held directly holds 1,258 shares of BCP Investment Corp. The transaction occurred as the shares traded in the vicinity of their 52-week low of $7.15; the stock is currently quoted at $7.45 after a one-week decline of 10%.

Data cited from InvestingPro notes that BCIC carries a dividend yield of 22% and is among more than 1,400 U.S. equities covered by InvestingPros Pro Research Reports.


Quarterly performance highlights

BCP Investment reported fourth-quarter 2025 results that exceeded analyst expectations on both earnings and revenue. The company recorded earnings per share of $0.57, outpacing the forecast of $0.5325 by 7.04%. Revenue for the quarter reached $17.5 million versus an expected $16.98 million.

Despite the top-line and EPS beats, Keefe, Bruyette & Woods reduced its price target on BCP Investment from $14.00 to $9.00 while maintaining a Market Perform rating. The firm called attention to a challenging quarter, pointing to net investment income that fell short of expectations and a net asset value that declined by 5% in the period. BCP Investment reported an operating return on equity of 7% for the quarter.

These developments present a mixed picture: earnings and revenue exceeded consensus, yet other key metrics reflected operational pressure.


Context for investors

  • Insider purchase: A Form 4 filing records a small-scale acquisition by a senior officer, adding 938 shares at $7.35 on March 23, 2026.
  • Share position: After the purchase, Held owns 1,258 shares directly.
  • Company results: Q4 2025 EPS and revenue topped analyst estimates; NAV fell 5% and net investment income missed expectations, per Keefe, Bruyette & Woods.

Readers should note that the facts above are drawn from the companys regulatory filing, third-party data points, and the research house commentary disclosed in company reporting.

Risks

  • Net investment income underperformance and a 5% decline in net asset value highlight earnings quality and valuation risks for investors in BCP Investment - impacting the financials and investment management sectors.
  • Share-price volatility is evident with a 10% one-week decline and proximity to the 52-week low, signaling market sensitivity in the closed-end fund and broader markets sector.
  • Analyst revisions, such as KBWs price-target reduction from $14.00 to $9.00 while keeping a Market Perform rating, introduce uncertainty around near-term valuation expectations - affecting investor sentiment in financial equities.

More from Insider Trading

Quantum-Si CEO Executes Sell-to-Cover Transactions Worth $19,906; Shares Near 52-Week Low Mar 24, 2026 4D Molecular VP Disposes $3,357 in Stock as Insider Activity Coincides with Clinical Milestones Mar 24, 2026 Diamondback Energy CAO Sells $965,000 in Stock as Company Posts Strong Q4 2025 Production Mar 24, 2026 Diamondback Energy COO Disposes Nearly $960,000 in Stock as Company Sees Multiple Corporate Moves Mar 24, 2026 Pharmacy Investors Sells Stake in Guardian Pharmacy for $24.6M Amid Active Capital Moves Mar 24, 2026